J. P. Arancibia

Operational tolerance after liver transplantation, more common than we think: a case report.

C. Benítez, J. P. Arancibia, M. Arrese, 2011, Annals of hepatology.

IDENTIFICATION OF OPTIMAL THERAPEUTIC WINDOW FOR STEROID USE IN SEVERE ALCOHOL-ASSOCIATED HEPATITIS: A WORLDWIDE STUDY.

Muhammad Tariq Majeed, Douglas A. Simonetto, R. Bataller, 2021, Journal of hepatology.

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

L. Kupčinskas, D. Ben Bashat, A. Sanyal, 2021, Nature Medicine.

Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review.

J. P. Arancibia, M. Arrese, A. Soza, 2014, World journal of gastroenterology.

Liver Disease: A Neglected Complication of Diabetes Mellitus

J. P. Arancibia, M. Arrese, J. Arab, 2012 .

Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus.

C. Benítez, J. P. Arancibia, M. Arrese, 2016, World journal of hepatology.

A comparative analysis of the Spanish and Latin-American prospective drug-induced liver injury (DILI) networks

C. Stephens, M. Lucena, M. Girala, 2015 .

Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus.

C. Benítez, J. P. Arancibia, M. Arrese, 2016, World journal of hepatology.